Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience.

MLA

Kwan, Caitlyn, et al. “Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience.” Advances in Radiation Oncology, vol. 9, no. 4, Jan. 2024, p. 101439. EBSCOhost, https://doi.org/10.1016/j.adro.2024.101439.

APA

Kwan, C., Chen, Y.-H., Killoran, J. H., Ferrone, M., Marcus, K. J., Tanguturi, S., Balboni, T. A., Spektor, A., & Huynh, M. A. (2024). Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience. Advances in Radiation Oncology, 9(4), 101439. https://doi.org/10.1016/j.adro.2024.101439

Chicago

Kwan, Caitlyn, Yu-Hui Chen, Joseph H Killoran, Marco Ferrone, Karen J Marcus, Shyam Tanguturi, Tracy A Balboni, Alexander Spektor, and Mai Anh Huynh. 2024. “Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience.” Advances in Radiation Oncology 9 (4): 101439. doi:10.1016/j.adro.2024.101439.